153 related articles for article (PubMed ID: 9484941)
1. 9p21 deletion correlates with recurrence in head and neck cancer.
Lydiatt WM; Davidson BJ; Schantz SP; Caruana S; Chaganti RS
Head Neck; 1998 Mar; 20(2):113-8. PubMed ID: 9484941
[TBL] [Abstract][Full Text] [Related]
2. Homozygous deletions and loss of expression of the CDKN2 gene occur frequently in head and neck squamous cell carcinoma cell lines but infrequently in primary tumors.
Lydiatt WM; Murty VV; Davidson BJ; Xu L; Dyomina K; Sacks PG; Schantz SP; Chaganti RS
Genes Chromosomes Cancer; 1995 Jun; 13(2):94-8. PubMed ID: 7542912
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.
Wiest JS; Franklin WA; Otstot JT; Forbey K; Varella-Garcia M; Rao K; Drabkin H; Gemmill R; Ahrent S; Sidransky D; Saccomanno G; Fountain JW; Anderson MW
Cancer Res; 1997 Jan; 57(1):1-6. PubMed ID: 8988029
[TBL] [Abstract][Full Text] [Related]
4. Deletion analysis of the p16/CDKN2 gene in head and neck squamous cell carcinoma using quantitative polymerase chain reaction method.
Rawnsley JD; Srivatsan ES; Chakrabarti R; Billings KR; Wang MB
Arch Otolaryngol Head Neck Surg; 1997 Aug; 123(8):863-7. PubMed ID: 9260553
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
6. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
7. Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas.
Gorgoulis VG; Koutroumbi EN; Kotsinas A; Zacharatos P; Markopoulos C; Giannikos L; Kyriakou V; Voulgaris Z; Gogas I; Kittas C
Mol Med; 1998 Dec; 4(12):807-22. PubMed ID: 9990866
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.
González MV; Pello MF; López-Larrea C; Suárez C; Menéndez MJ; Coto E
Clin Cancer Res; 1995 Sep; 1(9):1043-9. PubMed ID: 9816078
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
[TBL] [Abstract][Full Text] [Related]
10. Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16INK4a.
Waber P; Dlugosz S; Cheng QC; Truelson J; Nisen PD
Oncogene; 1997 Oct; 15(14):1699-704. PubMed ID: 9349503
[TBL] [Abstract][Full Text] [Related]
11. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
Xu X; An Q; Zhang J; Tang P; Cheng S
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
[TBL] [Abstract][Full Text] [Related]
12. Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer.
An HX; Niederacher D; Picard F; van Roeyen C; Bender HG; Beckmann MW
Genes Chromosomes Cancer; 1996 Sep; 17(1):14-20. PubMed ID: 8889502
[TBL] [Abstract][Full Text] [Related]
13. [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma].
Koscielny S; V Eggeling F; Dahse R
Laryngorhinootologie; 2004 Jun; 83(6):374-80. PubMed ID: 15197677
[TBL] [Abstract][Full Text] [Related]
14. Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.
Friedrich MG; Blind C; Milde-Langosch K; Erbersdobler A; Conrad S; Löning T; Hammerer P; Huland H
Eur Urol; 2001 Nov; 40(5):518-24. PubMed ID: 11752859
[TBL] [Abstract][Full Text] [Related]
15. Codeletion of the genes for p16INK4, methylthioadenosine phosphorylase, interferon-alpha1, interferon-beta1, and other 9p21 markers in human malignant cell lines.
Zhang H; Chen ZH; Savarese TM
Cancer Genet Cytogenet; 1996 Jan; 86(1):22-8. PubMed ID: 8616780
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma.
Coon SW; Savera AT; Zarbo RJ; Benninger MS; Chase GA; Rybicki BA; Van Dyke DL
Int J Cancer; 2004 Aug; 111(2):206-12. PubMed ID: 15197772
[TBL] [Abstract][Full Text] [Related]
17. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma.
Ohta M; Berd D; Shimizu M; Nagai H; Cotticelli M-G ; Mastrangelo M; Shields JA; Shields CL; Croce CM; Huebner K
Int J Cancer; 1996 Mar; 65(6):762-7. PubMed ID: 8631588
[TBL] [Abstract][Full Text] [Related]
18. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression.
van der Riet P; Nawroz H; Hruban RH; Corio R; Tokino K; Koch W; Sidransky D
Cancer Res; 1994 Mar; 54(5):1156-8. PubMed ID: 8118798
[TBL] [Abstract][Full Text] [Related]
19. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
[TBL] [Abstract][Full Text] [Related]
20. High frequency of deletion on chromosome 9p21 may harbor several tumor-suppressor genes in human prostate cancer.
Perinchery G; Bukurov N; Nakajima K; Chang J; Li LC; Dahiya R
Int J Cancer; 1999 Nov; 83(5):610-4. PubMed ID: 10521795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
